![Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined | PNAS Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined | PNAS](https://www.pnas.org/cms/10.1073/pnas.1521142113/asset/afea5d1b-fd5b-4f17-beb6-e4b1583c82f1/assets/graphic/pnas.1521142113fig04.jpeg)
Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined | PNAS
![Factor H binding proteins protect division septa on encapsulated Streptococcus pneumoniae against complement C3b deposition and amplification | Nature Communications Factor H binding proteins protect division septa on encapsulated Streptococcus pneumoniae against complement C3b deposition and amplification | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-018-05494-w/MediaObjects/41467_2018_5494_Fig8_HTML.png)
Factor H binding proteins protect division septa on encapsulated Streptococcus pneumoniae against complement C3b deposition and amplification | Nature Communications
![JCM | Free Full-Text | Heart-Type Fatty Acid-Binding Protein (H-FABP) and Its Role as a Biomarker in Heart Failure: What Do We Know So Far? JCM | Free Full-Text | Heart-Type Fatty Acid-Binding Protein (H-FABP) and Its Role as a Biomarker in Heart Failure: What Do We Know So Far?](https://pub.mdpi-res.com/jcm/jcm-09-00164/article_deploy/html/images/jcm-09-00164-ag.png?1581024265)
JCM | Free Full-Text | Heart-Type Fatty Acid-Binding Protein (H-FABP) and Its Role as a Biomarker in Heart Failure: What Do We Know So Far?
![Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1–9 years: two phase 2 randomised, controlled, observer-blinded Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1–9 years: two phase 2 randomised, controlled, observer-blinded](https://www.thelancet.com/cms/asset/9f43b942-9ecd-4881-a1e6-d750db1710c4/gr1a.jpg)
Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1–9 years: two phase 2 randomised, controlled, observer-blinded
Distinct modes of Si–H binding to Rh in complexes of a phosphine-diarylamido-silane (SiNP) pincer ligand - Dalton Transactions (RSC Publishing)
Protein-DNA H-bonding. We pick the example case glutamine chain binding... | Download Scientific Diagram
![Dual interaction of factor H with C3d and glycosaminoglycans in host–nonhost discrimination by complement | PNAS Dual interaction of factor H with C3d and glycosaminoglycans in host–nonhost discrimination by complement | PNAS](https://www.pnas.org/cms/10.1073/pnas.1017087108/asset/261fc006-d29e-4e5e-90ad-049253124df9/assets/graphic/pnas.1017087108fig04.jpeg)
Dual interaction of factor H with C3d and glycosaminoglycans in host–nonhost discrimination by complement | PNAS
![Polymorphic factor H-binding activity of CspA protects Lyme borreliae from the host complement in feeding ticks to facilitate tick-to-host transmission Polymorphic factor H-binding activity of CspA protects Lyme borreliae from the host complement in feeding ticks to facilitate tick-to-host transmission](https://repository.escholarship.umassmed.edu/bitstream/handle/20.500.14038/40672/journal.ppat.1007106.pdf.jpg?sequence=4&isAllowed=y)
Polymorphic factor H-binding activity of CspA protects Lyme borreliae from the host complement in feeding ticks to facilitate tick-to-host transmission
![Meningococcal factor H-binding protein: implications for disease susceptibility, virulence, and vaccines: Trends in Microbiology Meningococcal factor H-binding protein: implications for disease susceptibility, virulence, and vaccines: Trends in Microbiology](https://www.cell.com/cms/attachment/32944f9b-f5c0-4db1-9f86-1d631b04689c/gr1.jpg)
Meningococcal factor H-binding protein: implications for disease susceptibility, virulence, and vaccines: Trends in Microbiology
![The Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease - Canada.ca The Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease - Canada.ca](https://www.canada.ca/content/dam/phac-aspc/images/services/publications/vaccines-immunization/bivalent-factor-h-binding-protein-meningococcal-serogroup-b-prevention-meningococcal-b-disease/bivalent-factor-h-binding-protein-meningococcal-serogroup-b-prevention-meningococcal-b-disease-thumb.jpg)